Is SINTX Technologies Inc (SINT) overvalued? · rev $2.9M
SINTX Technologies Inc (SINT) is a medical devices company listed on US.
This page asks whether SINTX Technologies Inc (SINT) looks expensive on cached numbers — not a short thesis.
Latest reported SINT revenue for 2024-12-31 was $2.9M. Net income was -$11.0M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. SINT currently screens at market cap $12.6M.
SINT currently screens at market cap $12.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SINT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SINT stock page for the full model, not this heading.
Not investment advice.